|
Facebook
Twitter
Linkedin
|
 |
 |
 |
 |
Healthcare Company News 
Varian Medical Systems Yashoda Cancer Institute Treats First Patient in India Using Varian's RapidArc
Varian Medical Systems Yashoda Cancer Institute Treats First Patient in India Using Varian's RapidArc
Yashoda Cancer Institute Treats First Patient in India Using Varian's RapidArc
Tuesday, 21 April 2009 07:30 | 
| Company News - Varian Medical Systems |
Yashoda Cancer Institute Treats First Patient in India Using RapidArc Radiotherapy Technology
Clinicians in India have carried out the country's first treatment using a new, faster form of radiotherapy that extends more advanced care to more patients. A 72-year-old bladder cancer patient received the pioneering treatment using RapidArc radiotherapy technology from Varian Medical Systems at Yashoda Cancer Institute in Hyderabad.
Varian's RapidArc technology makes it possible to deliver image-guided IMRT (intensity modulated radiotherapy) two to eight times faster than is possible with conventional IMRT. RapidArc delivers a precise and efficient treatment in single or multiple arcs of the treatment machine around the patient and offers several advantages over traditional approaches, according to clinician Dr. Srinivas Chilikuri.
"The whole treatment duration including set-up and check was completed in ten minutes, which involved just 90 seconds of 'beam-on' time," said Dr. Chilikuri. "We witnessed high dose conformity, excellent target coverage and good critical tissue sparing but the main advantage was the speed of the treatment."
Dr. Chilikuri said speed is particularly important because of the large number of cancer patients in India. "In a country like ours with a heavy cancer burden there is a real issue with waiting lists," he said. "We deal with this by prioritising and optimizing treatment facilities and RapidArc is an excellent example of this approach. With this, we can carry out faster and more precise treatments with less complex delivery and less complicated quality assurance requirements.
"The whole point of acquiring RapidArc was to treat more and more patients with high precision technology. With RapidArc's fast and efficient treatment delivery we will significantly increase the number of patients treated with advanced conformal techniques."
Dr. Chilikuri said the clinical team at Yashoda plans to use RapidArc for a variety of common cancers such as head & neck, cervical, prostate and lung, as well as complicated tumors which are otherwise difficult to treat with other techniques.
Yashoda Cancer Institute is an international quality 200 bed comprehensive cancer research and treatment center operated by Yashoda Hospitals. The cancer institute provides healthcare to 7,000 cancer patients every year. A comprehensive cancer center with state-of-the-art technology, the hospital treats patients from south and east India, South Asia and the Middle East. Dheeraj Gorukanti, chief executive officer of Yashoda Hospitals Group, said, "Yashoda Hospitals is proud to be one of the first sites in the world to implement Varian's RapidArc system. We believe it will provide a real edge in helping patients fight cancer."
About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. For more information, visit http://www.varian.com/.
Source: Varian Medical Systems
Varian's RapidArc technology makes it possible to deliver image-guided IMRT (intensity modulated radiotherapy) two to eight times faster than is possible with conventional IMRT. RapidArc delivers a precise and efficient treatment in single or multiple arcs of the treatment machine around the patient and offers several advantages over traditional approaches, according to clinician Dr. Srinivas Chilikuri.
"The whole treatment duration including set-up and check was completed in ten minutes, which involved just 90 seconds of 'beam-on' time," said Dr. Chilikuri. "We witnessed high dose conformity, excellent target coverage and good critical tissue sparing but the main advantage was the speed of the treatment."
Dr. Chilikuri said speed is particularly important because of the large number of cancer patients in India. "In a country like ours with a heavy cancer burden there is a real issue with waiting lists," he said. "We deal with this by prioritising and optimizing treatment facilities and RapidArc is an excellent example of this approach. With this, we can carry out faster and more precise treatments with less complex delivery and less complicated quality assurance requirements.
"The whole point of acquiring RapidArc was to treat more and more patients with high precision technology. With RapidArc's fast and efficient treatment delivery we will significantly increase the number of patients treated with advanced conformal techniques."
Dr. Chilikuri said the clinical team at Yashoda plans to use RapidArc for a variety of common cancers such as head & neck, cervical, prostate and lung, as well as complicated tumors which are otherwise difficult to treat with other techniques.
Yashoda Cancer Institute is an international quality 200 bed comprehensive cancer research and treatment center operated by Yashoda Hospitals. The cancer institute provides healthcare to 7,000 cancer patients every year. A comprehensive cancer center with state-of-the-art technology, the hospital treats patients from south and east India, South Asia and the Middle East. Dheeraj Gorukanti, chief executive officer of Yashoda Hospitals Group, said, "Yashoda Hospitals is proud to be one of the first sites in the world to implement Varian's RapidArc system. We believe it will provide a real edge in helping patients fight cancer."
About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. For more information, visit http://www.varian.com/.
Source: Varian Medical Systems
